DE602004015260D1 - S beta-2-agonist in verbindung mit anderen wirkstoffen - Google Patents

S beta-2-agonist in verbindung mit anderen wirkstoffen

Info

Publication number
DE602004015260D1
DE602004015260D1 DE602004015260T DE602004015260T DE602004015260D1 DE 602004015260 D1 DE602004015260 D1 DE 602004015260D1 DE 602004015260 T DE602004015260 T DE 602004015260T DE 602004015260 T DE602004015260 T DE 602004015260T DE 602004015260 D1 DE602004015260 D1 DE 602004015260D1
Authority
DE
Germany
Prior art keywords
agonist
beta
connection
active substances
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015260T
Other languages
English (en)
Inventor
Roberta Razzetti
Fiorella Pastore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32748803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004015260(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE602004015260D1 publication Critical patent/DE602004015260D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602004015260T 2003-02-27 2004-02-27 S beta-2-agonist in verbindung mit anderen wirkstoffen Expired - Lifetime DE602004015260D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03004184A EP1452179A1 (de) 2003-02-27 2003-02-27 Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
PCT/EP2004/001960 WO2004075896A1 (en) 2003-02-27 2004-02-27 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

Publications (1)

Publication Number Publication Date
DE602004015260D1 true DE602004015260D1 (de) 2008-09-04

Family

ID=32748803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015260T Expired - Lifetime DE602004015260D1 (de) 2003-02-27 2004-02-27 S beta-2-agonist in verbindung mit anderen wirkstoffen

Country Status (32)

Country Link
US (1) US20070020190A1 (de)
EP (3) EP1452179A1 (de)
JP (1) JP2006519204A (de)
KR (1) KR20050104367A (de)
CN (2) CN100370986C (de)
AR (1) AR043419A1 (de)
AT (1) ATE401887T1 (de)
AU (1) AU2004216472B2 (de)
BR (1) BRPI0408047A (de)
CA (1) CA2517321A1 (de)
CY (1) CY1108360T1 (de)
DE (1) DE602004015260D1 (de)
DK (1) DK1603565T3 (de)
EA (1) EA008828B1 (de)
ES (1) ES2309503T3 (de)
HK (1) HK1087009A1 (de)
HR (1) HRP20050726A2 (de)
MA (1) MA27630A1 (de)
ME (1) MEP32208A (de)
MX (1) MXPA05009007A (de)
NO (1) NO20053959L (de)
NZ (1) NZ541997A (de)
PE (1) PE20050290A1 (de)
PL (1) PL377814A1 (de)
PT (1) PT1603565E (de)
RS (1) RS20050615A (de)
SA (1) SA04250122B1 (de)
SI (1) SI1603565T1 (de)
TN (1) TNSN05186A1 (de)
UA (1) UA82217C2 (de)
WO (1) WO2004075896A1 (de)
ZA (1) ZA200506820B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
EP1654001A2 (de) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medikamente zur inhalation mit steroiden und einem betamimetikum
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
SI1863476T1 (sl) * 2005-03-16 2016-05-31 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
WO2006105401A2 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
DE602006010088D1 (de) * 2005-08-01 2009-12-10 Chiesi Farma Spa Pharmazeutische formulierungen mit einem langzeit-beta-2-agonisten zur verabreichung durch verneblung
ATE529399T1 (de) * 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
CA2632780C (en) * 2005-12-21 2013-11-12 Meda Pharma Gmbh & Co. Kg Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
WO2007135024A1 (en) * 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh New long-acting drug combinations for the treatment of respiratory diseases
EP1953143A1 (de) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid
JP2010519195A (ja) * 2007-02-19 2010-06-03 シプラ・リミテッド 薬学的組成物
EP2534958A1 (de) 2007-12-14 2012-12-19 AeroDesigns, Inc Abgabe von Aerosol-sprühbaren Nahrungsmittelprodukten
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
WO2010097188A1 (en) * 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
JP2012527490A (ja) * 2009-05-25 2012-11-08 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 肺表面活性物質およびステロイドを有する治療的組み合わせ
AU2010253776B2 (en) 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
WO2011136753A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
CN102247597B (zh) * 2010-05-19 2015-01-07 天津金耀集团有限公司 一种糖皮质激素与支气管扩张剂的吸入剂
BR112013001119A2 (pt) 2010-07-16 2016-05-24 Cipla Ltd composição farmacêutica, processo para fabricar uma composição farmacêutica, uso de r(+)budesonida e um broncodilatador, e método de profilaxia ou tratamento de uma doença respiratória, inflamatória ou obstrutiva das vias aéreas
WO2012010854A1 (en) 2010-07-23 2012-01-26 Cipla Limited Inhalation formulations comprising carmoterol in combination with a corticosteroid
CN102416179B (zh) * 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
SI2968313T1 (en) * 2013-03-15 2018-05-31 Verona Pharma Plc Combination of medicines
US10117891B2 (en) 2014-09-16 2018-11-06 India Globalization Capital, Inc. Cannabinoid composition for treating pain
EP3223807B1 (de) 2014-11-24 2021-09-15 The Board of Trustees of the University of Illinois Verfahren zur vorbeugung oder behandlung einer lungenerkrankung oder -störung
EP3247359A4 (de) 2015-01-25 2018-08-08 India Globalization Capital, Inc. Zusammensetzungen und verfahren zur behandlung von krampfanfällen
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
EP3471746A4 (de) 2016-06-15 2020-02-26 India Globalization Capital, Inc. Verfahren und zusammensetzung zur behandlung von krampfanfällen
CN115337311B (zh) * 2022-09-26 2023-05-09 南京恒道医药科技股份有限公司 一种治疗呼吸系统疾病的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ES2316681T3 (es) * 1997-03-20 2009-04-16 Schering Corporation Formas de dosificacion de aglomerados en polvo.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US20020081266A1 (en) * 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
EP1340492A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
EP1595531A1 (de) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren

Also Published As

Publication number Publication date
PT1603565E (pt) 2008-10-06
EP1452179A1 (de) 2004-09-01
CN1753678A (zh) 2006-03-29
ATE401887T1 (de) 2008-08-15
TNSN05186A1 (en) 2007-06-11
CN100370986C (zh) 2008-02-27
US20070020190A1 (en) 2007-01-25
JP2006519204A (ja) 2006-08-24
EA200501108A1 (ru) 2006-04-28
RS20050615A (en) 2007-09-21
CA2517321A1 (en) 2004-09-10
PL377814A1 (pl) 2006-02-20
ES2309503T3 (es) 2008-12-16
NO20053959D0 (no) 2005-08-25
SI1603565T1 (sl) 2008-10-31
MA27630A1 (fr) 2005-11-01
ZA200506820B (en) 2006-11-29
EP1834643A3 (de) 2007-10-24
WO2004075896A1 (en) 2004-09-10
EP1603565A1 (de) 2005-12-14
AU2004216472A1 (en) 2004-09-10
DK1603565T3 (da) 2008-11-10
HK1087009A1 (en) 2006-10-06
NO20053959L (no) 2005-11-28
EA008828B1 (ru) 2007-08-31
UA82217C2 (uk) 2008-03-25
HRP20050726A2 (en) 2006-02-28
EP1603565B1 (de) 2008-07-23
EP1834643A2 (de) 2007-09-19
CN101244063A (zh) 2008-08-20
MEP32208A (en) 2010-10-10
BRPI0408047A (pt) 2006-02-14
KR20050104367A (ko) 2005-11-02
AU2004216472B2 (en) 2009-08-06
NZ541997A (en) 2008-12-24
MXPA05009007A (es) 2005-10-18
SA04250122B1 (ar) 2009-03-11
PE20050290A1 (es) 2005-05-26
CY1108360T1 (el) 2014-02-12
AR043419A1 (es) 2005-07-27

Similar Documents

Publication Publication Date Title
DE602004015260D1 (de) S beta-2-agonist in verbindung mit anderen wirkstoffen
CY2015006I2 (el) Συνδυασμοι που περιλαμβανουν αντιμουσκαρινικους παραγοντες και βητα-αδρενεργικους αγωνιστες
DE60310935D1 (de) Aktive luer-verbindung mit membrane und behälter mit verbindung
PL1771576T3 (pl) Substancje czynne do wzmożenia zwalczania patogenów w roślinach i metody ich wykrywania
IS2672B (is) Asíþrómýsín lyfjaskammtaform með minni hliðarverkanir
DE60311076D1 (de) Nanostrukturen mit pilin-protein
ITMI20040079A1 (it) Cingolo avente una boccola rotante e articolazione per lo stesso
DE602004014736D1 (de) Sitzvorrichtung mit rücklehnenverriegelung
ITTO20030152A1 (it) Sedia con sedile oscillante.
BR8203013Y1 (pt) disposição em tanque agitador usado em produtos cosméticos.
FI20045182A0 (fi) Tiedonsiirto UMTS järjestelmässä
EP1608729A4 (de) Rnai-arrays und verfahren zur verwendung davon
DE60327759D1 (de) Vorrichtung in verbindung mit schrittmachern
ITBS20030036A1 (it) Recipiente con dispositivo per rimestare e distribuire la polenta.
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
ITRM20040242A1 (it) "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
PT102903A (pt) Aperfeicoamentos introduzidos nas unioes estanques para juncao de tubagens com extremos lisos
FR2852021B1 (fr) Methodes et outils pour le criblage d'arn actifs in cellulo
Ball Beating the lights
文熠 About Pollution
ITPI20030083A1 (it) Bottale con perfezionamenti costruttivi adatti, in
Dill Defining Success for Small Businesses in Parksville and how Malaspina University-College Can Help
FI5933U1 (fi) Järjestely kuormankiristimen yhteydessä
邓妍祯 AN UNFORGETTABLE DAY

Legal Events

Date Code Title Description
8364 No opposition during term of opposition